Nova Treatment Community Inc
Analysis
Nova Treatment Community Inc is a registered charity in United States, based in Omaha, NE. It received its IRS tax-exemption ruling in April 1985, 41 years ago. Its declared purposes cover mental health and crisis intervention, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.
In the financial year ending June 2023, Nova Treatment Community Inc reported income of $4.9m and spending of $5.3m, spending 107% of what it took in. Across the 5 years on record, from June 2019 to June 2023, income fell from $5.1m to $4.9m (-3.6%), an average of -0.9% a year. Over the whole period it spent 101% of the income it received.
Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Nova Treatment Community Inc sits at the 79th percentile: it is larger than about 79% of them. Against every charity in United States with reported income it ranks in the 92nd percentile, and in the 91st percentile within NE. Charities of a similar size with the same main cause include Ecdysis Foundation ($4.9m), Westcare Kentucky Inc ($4.9m) and Go-Getters Inc ($4.9m).
On its Form 990 for the period ending June 2023, revenue came from contributions and grants 59% and program service revenue 41% of the total. Compensation of current officers, directors and key employees was $208k (3.9% of expenses). Other salaries and wages came to $2.6m. At year end it held assets of $3.3m against liabilities of $1.8m, net assets of $1.4m. It reported 87 employees.
Income and spending
Where the income comes from
- Contributions & grants 59%
- Program services 41%
Similar-sized charities, same cause
| Charity | Location | Income |
|---|---|---|
| Ecdysis Foundation | Estelline | $4.9m |
| Westcare Kentucky Inc | Henderson | $4.9m |
| Go-Getters Inc | Salisbury | $4.9m |
| Jericho Project | Brisbane | $4.9m |